July 24th, 2024, from 3:00 PM ET – 4:15 PM ET
Session Description:
-
- This virtual symposium will have 2 highly regarded faculty speakers. The program design allows for a high level of interactivity with case-based discussion and Q&A as well as breaks in the faculty presentations where the learners utilize Whiteboard and 2D Ultra 4K HD animations to reduce the cognitive load required for uptake of key learnings on the mechanism of action of CD3 and CD20 antagonists and their roles in T1D disease etiopathogenesis as well as clinical monitoring for autoantibody positive individuals: glucometer testing, HbA1c, OGTT, etc. and frequency in use. In addition, we will also be partnering with the Public Health Foundation (PHF) for program awareness and for simulcasting the live program through their network, which will vastly extend the reach of this education.
Speakers/Faculty:
Dr. Richard Oram, MD, PhD, BMBCh, MRCP
Associate Professor, Diabetes UK Harry Keen Fellow
Institute of Biomedical and Clinical Science and NIHR Exeter Clinical Research Facility
Exeter, UK
Emily K. Sims, MD
Pediatric Endocrinologist
Riley Hospital for Children
Indianapolis, IN
Learning Objectives: Upon completion of one or more of the proposed activities and using the resources provided, HCPs will have improved ability to:
-
- Describe the clinical presentation of T1D in adults compared to children
- Identify appropriate autoantibody screening strategies for T1D, including type, frequency, and number
- Interpret results from screening protocols to drive management decisions
- Discuss the latest clinical evidence for efficacy and tolerability of newly approved and investigational immunomodulatory agents
- Implement strategies for appropriate clinical monitoring and early screening in individuals at highest risk
CME
-
- In support of improving patient care, Med Learning Group is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team. Med Learning Group will designate this satellite symposium and simulcast for a maximum of 1.25 AMA PRA Category 1 Credits™. Med Learning Group designates this activity for a maximum of 1.25 ANCC Contact Hours.
- The American Medical Association (AMA) has an agreement of mutual recognition of continuing medical education (CME) credit with the European Union of Medical Specialties (UEMS). Under the terms of this agreement, the AMA will convert CME credit for live and e-learning activities certified by the European Accreditation Council for Continuing Medical Education (EACCME), the accrediting arm of the UEMS, to AMA PRA Category 1 Credit™. The renewed agreement is in place through July 31, 2026.